Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Disclosure statements are available on the authors' profiles:
Cardiovascular Safety in Type 2 Diabetes With Sulfonylureas as Second-line Drugs: A Nationwide Population-Based Comparative Safety StudyDiabetes Care 2023 May 01;46(5)967-977, H Wang, RLM Cordiner, Y Huang, L Donnelly, S Hapca, A Collier, J McKnight, B Kennon, F Gibb, P McKeigue, SH Wild, H Colhoun, J Chalmers, J Petrie, N Sattar, T MacDonald, RJ McCrimmon, DR Morales, ER Pearson
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.